The earnings call reflected a balanced sentiment with strong performance in certain segments like on! nicotine pouches and increased shareholder returns, contrasted by declines in cigarette volumes and challenges related to NJOY and patent disputes. The guidance increase indicates confidence in future performance.

Company Guidance -

Q3 2025

During the Altria Group's 2025 second quarter earnings call, several key metrics and projections were discussed. The company reported a robust adjusted diluted earnings per share (EPS) increase of 8.3% to $1.44 for the second quarter and a 7.2% increase for the first half. Altria raised the lower end of its 2025 guidance range, now expecting adjusted diluted EPS to be between $5.35 and $5.45, reflecting a growth rate of 3% to 5% from the 2024 base. The oral tobacco segment saw impressive growth, with on! nicotine pouches increasing shipment volume by 26.5% to 52.1 million cans, achieving a retail share of 8.7%. Additionally, the smokable products segment's adjusted operating companies income grew by 4.2% to $2.9 billion in the second quarter. The call also highlighted the company's efforts in the regulatory landscape and its ongoing advocacy for FDA enforcement against illicit e-vapor products. Altria continued to return value to shareholders with $3.5 billion in dividends and $600 million in share repurchases during the first half of the year, maintaining a strong balance sheet with a total debt-to-EBITDA ratio of 2.0x.

Strong Performance of on! Nicotine Pouches

on! nicotine pouches continued to drive growth in the oral tobacco segment with a reported shipment volume increase of 26.5% to 52.1 million cans year-over-year.

Increased Guidance for 2025

Altria raised the lower end of its 2025 EPS guidance range, now expecting adjusted diluted EPS to be between $5.35 and $5.45, representing a growth rate of 3% to 5% from a base of $5.19 in 2024.

Strong Shareholder Returns

Altria returned significant value to shareholders with approximately $3.5 billion in dividends and repurchased 10.4 million shares for $600 million in the first half of the year.

Growth in Oral Tobacco Products Segment

The oral tobacco products segment saw an impressive adjusted operating companies income (OCI) growth of 10.9% in the second quarter.

Altria Group (MO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	1.44 / -	1.38	―	―	―
Jul 30, 2025	2025 (Q2)	1.39 / 1.44	1.31	9.92% (+0.13)
Apr 29, 2025	2025 (Q1)	1.19 / 1.23	1.15	6.96% (+0.08)
Jan 30, 2025	2024 (Q4)	1.28 / 1.29	1.18	9.32% (+0.11)
Oct 31, 2024	2024 (Q3)	1.35 / 1.38	1.28	7.81% (+0.10)
Jul 31, 2024	2024 (Q2)	1.34 / 1.31	1.31	0.00% (0.00)
Apr 25, 2024	2024 (Q1)	1.15 / 1.15	1.18	-2.54% (-0.03)
Feb 01, 2024	2023 (Q4)	1.18 / 1.18	1.18	0.00% (0.00)
Oct 26, 2023	2023 (Q3)	1.29 / 1.28	1.28	0.00% (0.00)
Aug 01, 2023	2023 (Q2)	1.30 / 1.31	1.26	3.97% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$59.36	$61.50	+3.61%
Apr 29, 2025	$57.20	$57.77	+1.00%
Jan 30, 2025	$50.85	$49.76	-2.14%
Oct 31, 2024	$47.83	$51.58	+7.84%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.